TMEM59 regulates microglial Aβ phagocytosis in a TREM2-dependent manner and acts as a potential therapeutic target for Aβ amyloidosis.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AnimalsMicrogliaMembrane GlycoproteinsPhagocytosisReceptors, ImmunologicAmyloid beta-PeptidesMembrane ProteinsMiceAlzheimer DiseaseMice, TransgenicAmyloidosisNerve Tissue ProteinsDisease Models, AnimalPlaque, AmyloidAlzheimer's diseaseTMEM59TREM2amyloidchaperone‐mediated autophagy‐targeting chimeramicrogliaphagocytosistransmembrane protein 59triggering receptor expressed on myeloid cells 2
Come citare questo studio
Jian Meng, Yong Wang, Jinghui Wang, Yiqing Chen, Zihao Zhao, Ziqian Tang, Jing Cao, Xian Zhang, Hong Luo, Huihui Li, Yili Wu, Yingjun Zhao, Weihong Song, Yun-Wu Zhang. (2026). TMEM59 regulates microglial Aβ phagocytosis in a TREM2-dependent manner and acts as a potential therapeutic target for Aβ amyloidosis.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71873
Consulta la pubblicazione originale ↗